C-Reactive Protein (CRP) and Chronic Disease Risk
C-reactive protein (CRP) is a globular protein produced by the liver in response to inflammation. Elevated CRP is now recognized as one of the most reliable blood markers for predicting cardiovascular risk—and in many cases, it outperforms traditional markers like LDL cholesterol.
CRP as a Predictor of Heart Disease
A large study in the Journal of the American Nutraceutical Association (2005;8(1):43–44), involving more than 27,000 women, found that CRP was actually a better predictor of cardiovascular disease than LDL (“bad”) cholesterol.
High CRP and Risk of Death
Inflammation affects more than the heart. Research in Clinical Chemistry (2008;54(2):335–342) found that men with CRP levels greater than 3 mg/L had:
-
Nearly double the risk of death from all causes
-
A 2.15-fold increase in heart attack risk
-
A 1.65-fold increase in cancer risk
This underscores the importance of tracking— and lowering—systemic inflammation.
Can Supplements Lower CRP?
A cross-sectional study in the European Journal of Nutrition (2008;62:127–137) evaluated more than 4,200 adults ages 25 to 74. Supplementation was associated with meaningful differences:
-
Vitamin and mineral use correlated with lower CRP levels in women (but not men)
-
The strongest association was seen with vitamin E combined with other nutrients
-
Combinations including vitamin E, vitamin C, B-complex vitamins (B1, B2, B6, B12, niacin, folic acid, pantothenic acid), and selenium were significantly linked to lower CRP
These findings suggest that targeted nutritional support—especially antioxidant and B-vitamin combinations—may help reduce inflammation in certain populations.
